These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27583698)

  • 1. Post-authorization safety study of Clottafact
    Négrier C; Rothschild C; Borg JY; Lambert T; Claeyssens S; Sanhes L; Stieltjes N; Bertrand A; André MH; Sié P; Gruel Y; Tellier Z
    Vox Sang; 2016 Nov; 111(4):383-390. PubMed ID: 27583698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postauthorization safety study of Clottafact
    Négrier C; Ducloy-Bouthors AS; Piriou V; De Maistre E; Stieltjes N; Borel-Derlon A; Colson P; Picard J; Lambert T; Claeyssens S; Boileau S; Bertrand A; André MH; Fourrier F; Ozier Y; Sié P; Gruel Y; Tellier Z
    Vox Sang; 2018 Feb; 113(2):120-127. PubMed ID: 29238971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency.
    Djambas Khayat C; El Khorassani M; Lambert T; Gay V; Barthez-Toullec M; Lamazure J; Bellon A; Henriet C; Bridey F; Négrier C
    J Thromb Haemost; 2019 Apr; 17(4):635-644. PubMed ID: 30661302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency.
    Ross C; Rangarajan S; Karimi M; Toogeh G; Apte S; Lissitchkov T; Acharya S; Manco-Johnson MJ; Srivastava A; Brand B; Schwartz BA; Knaub S; Peyvandi F
    J Thromb Haemost; 2018 Feb; 16(2):253-261. PubMed ID: 29220876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational Safety Study of Clottafact
    Colin-Bracamontes I; Pérez-Calatayud ÁA; Carrillo-Esper R; Rodríguez-Ayala E; Padilla-Molina M; Posadas-Nava A; Olvera-Vázquez S; Hernández-Salgado L
    Clin Drug Investig; 2020 May; 40(5):485-491. PubMed ID: 32215860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.
    Lissitchkov T; Madan B; Djambas Khayat C; Zozulya N; Ross C; Karimi M; Kavakli K; De Angulo GR; Almomen A; Schwartz BA; Solomon C; Knaub S; Peyvandi F
    Transfusion; 2018 Feb; 58(2):413-422. PubMed ID: 29194665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia.
    Djambas Khayat C; El Khorassani M; Aytaç S; Harroche A; Dahmane A; Pujol S; Henriet C; de Moerloose P; Bridey F
    Thromb Haemost; 2020 Jun; 120(6):957-967. PubMed ID: 32392604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic subdural hematoma in a patient with congenital afibrinogenemia successfully treated with fibrinogen replacement.
    Sakai N; Akamine S; Tokuyama T; Sugiyama K; Kanayama N; Namba H
    Neurol Med Chir (Tokyo); 2011; 51(11):780-3. PubMed ID: 22123482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of fibrinogen concentrate.
    Manco-Johnson MJ; Dimichele D; Castaman G; Fremann S; Knaub S; Kalina U; Peyvandi F; Piseddu G; Mannucci P;
    J Thromb Haemost; 2009 Dec; 7(12):2064-9. PubMed ID: 19804533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of congenital fibrinogen deficiency: overview and recent findings.
    Tziomalos K; Vakalopoulou S; Perifanis V; Garipidou V
    Vasc Health Risk Manag; 2009; 5():843-8. PubMed ID: 19851522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia.
    Gollop ND; Chilcott J; Benton A; Rayment R; Jones J; Collins PW
    Transfus Med; 2012 Oct; 22(5):350-5. PubMed ID: 22697297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen replacement therapy for congenital fibrinogen deficiency.
    Bornikova L; Peyvandi F; Allen G; Bernstein J; Manco-Johnson MJ
    J Thromb Haemost; 2011 Sep; 9(9):1687-704. PubMed ID: 21711446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions.
    Aygören-Pürsün E; Martinez Saguer I; Rusicke E; Louwen F; Geka F; Ivaskevicius V; Oldenburg J; Klingebiel T; Kreuz W
    Am J Hematol; 2007 Apr; 82(4):317-20. PubMed ID: 17034026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia.
    Khayat CD; Navarro-Puerto J; Ross CR; Subramanian K; Kalappanavar NK; Rucker K; Liang W; Mondou E
    Blood Coagul Fibrinolysis; 2023 Jan; 34(1):61-69. PubMed ID: 36484281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients.
    Lissitchkov T; Madan B; Djambas Khayat C; Zozulya N; Ross C; Karimi M; Kavakli K; De Angulo GR; Almomen A; Subramanian K; D'Souza F; Viswabandya A; Hoorfar H; Schwartz BA; Solomon C; Knaub S; Peyvandi F
    J Thromb Haemost; 2020 Apr; 18(4):815-824. PubMed ID: 31885190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.
    Bell SF; Rayment R; Collins PW; Collis RE
    Int J Obstet Anesth; 2010 Apr; 19(2):218-23. PubMed ID: 20194010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate.
    Négrier C; Rothschild C; Goudemand J; Borg JY; Claeyssens S; Alessi MC; Jaffry AC; Teboul C; Padrazzi B; Waegemans T
    J Thromb Haemost; 2008 Sep; 6(9):1494-9. PubMed ID: 18627444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.
    Peyvandi F
    Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative replacement therapy with fibrinogen concentrate in a patient with Klippel-Trenaunay syndrome and severe hypofibrinogenaemia.
    Coloma-Pérez M; Hernández-Palazón J; Fuentes-García D; Falcón-Araña L
    Br J Anaesth; 2013 May; 110(5):855-6. PubMed ID: 23599532
    [No Abstract]   [Full Text] [Related]  

  • 20. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
    Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.